NMTCB study guide UPDATED ACTUAL Questions and CORRECT Answers

NMTCB study guide UPDATED ACTUAL Questions and CORRECT Answers

TEDE < 0.5rem (5mSv)
Patient Release (therapy) TEDE to other individual < 0.1 rem (1mSv) with written
instructions
Ca+ analog that rapidly clears out of blood and localizes in
Palliative therapy:
areas of osteogenesis
Sr-89 Chloride
repeated every 12 weeks
BONE CANCER
Palliative therapy:
phosphate compound
Sm-153 Lexidronam
repeat t(x) every 12 weeks
BONE CANCER
Palliative therapy: accumulation in hydroxiapatite crytal of bone and non-os-
P-32 Sodium Phosphate seous tissue
Repeat every 12 weeks
Monoclonal antibody
Radioimmunotherapy for Non-Hodgkin's lymphoma
Palliative Therapy:
Rituximab infusion
Y-90 Zevalin
Zevalin 10 min infusion
Dose < 32mCi
LIVER CANCER
Palliative Therapy:
glass microspheres (20-30um)
Y-90 Microspheres
MAA shunting prior to therapy
Palliative Therapy: Prostate cancer
Ra-223 Dichloride (Xofigo) administration every 4 weeks for 6 weeks (6 injections)
22,000dpm/100cm^2
Wipe test trigger level
RSO must be notified
Restricted area Radiation limit > 2mrem in any one hour
Unrestricted area Rad limit < 2mRem in any one hour